Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
115 studies found for:    BEACON
Show Display Options
Rank Status Study
1 Recruiting BEACON Care ® System Assisting Ventilation in Pressure Support Ventilation (PSV) Patient
Condition: Artificial Respiration
Interventions: Device: Pressure Support Over Support;   Device: Pressure Support Under Support;   Device: PEEP Over Level;   Device: PEEP Under Level
2 Terminated The BEACON Registry: Best Expert Agreement for Care of Occult Myocardial Infarction (MI) Nationally
Condition: Chest Pain
Intervention:
3 Completed The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: NKTR-102;   Drug: Treatment of Physician's Choice (TPC)
4 Not yet recruiting Weaning From Mechanical Ventilation Comparison of Open-loop Decision Support System and Routine Care
Condition: Respiration, Artificial
Interventions: Device: open loop weaning group (Beacon);   Other: Routine care
5 Terminated Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Conditions: Renal Insufficiency, Chronic;   Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Bardoxolone Methyl: 20 mg
6 Recruiting Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
Condition: Neuroblastoma
Interventions: Drug: Bevacizumab;   Drug: Temozolomide;   Drug: Irinotecan;   Drug: Topotecan
7 Completed
Has Results
Intervention to Improve Care at Life's End
Conditions: Death;   Pain;   Dyspnea
Intervention: Behavioral: Comfort care education intervention
8 Unknown  Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions
Condition: Non-palpable Breast Lesions
Intervention: Device: RFID Tag (Health Beacon)
9 Completed Better Evaluation of Acute Chest Pain With Computed Tomography Angiography
Conditions: Acute Coronary Syndrome;   Acute Chest Pain
Intervention: Radiation: Cardiac CT
10 Completed
Has Results
Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Pre-surgical Treatment with Bevacizumab plus Chemotherapy;   Drug: Pre-Surgical Docetaxel and Cisplatin and Adjuvant Bevacizumab
11 Recruiting Blastocyst Euploidy Assessment and Conditioned embryO traNsfer
Condition: Infertility
Intervention: Other: PGS
12 Active, not recruiting Behavioral Economics for Advance Care Options
Condition: End of Life Care
Interventions: Behavioral: Counseling (Care giver burden focus);   Behavioral: Counseling (patient autonomy focus)
13 Active, not recruiting A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Conditions: Geographic Atrophy;   Macular Degeneration
Interventions: Drug: 400 µg Brimonidine Implant;   Other: Sham
14 Completed
Has Results
Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: QVA149;   Drug: NVA237;   Drug: QAB149;   Drug: Placebo
15 Completed
Has Results
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
Condition: Acute Schizophrenia
Interventions: Drug: OPC-34712;   Drug: Placebo
16 Completed Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment
Condition: Relapsing Remitting Multiple Sclerosis (RRMS)
Intervention: Drug: Interferon beta-1b (Betaseron, BAY86-5046)
17 Recruiting Evaluation of Methods for Implementation of a Comfort Care Order Set
Condition: Terminal Conditions, End of Life
Interventions: Other: Basic Implementation Approach;   Other: Enhanced Implementation Approach
18 Recruiting Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Condition: BRAF V600E-mutant Metastatic Colorectal Cancer
Interventions: Drug: Encorafenib;   Drug: Binimetinib;   Drug: Cetuximab;   Drug: Irinotecan;   Drug: Folinic Acid;   Drug: 5-Fluorouracil
19 Recruiting Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer
Condition: Non-small Cell Lung Cancer (NSCLC)
Intervention: Device: Calypso Beacon Implantation
20 Completed A Moderate to Severe Rheumatoid Arthritis Study
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo;   Drug: Baricitinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.